216 related articles for article (PubMed ID: 11862796)
1. [Preventing rejection, minimizing toxicity: optimized therapy with cyclosporin].
MMW Fortschr Med; 2002 Jan; 144(3-4):59. PubMed ID: 11862796
[No Abstract] [Full Text] [Related]
2. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study.
Ponticelli C; Salvadori M; Scolari MP; Citterio F; Rigotti P; Veneziano A; Bartezaghi M;
Transplantation; 2011 May; 91(10):e72-3. PubMed ID: 21540717
[No Abstract] [Full Text] [Related]
3. [Cylosporine posological individualization strategies in renal transplant patients].
Porta B; Pérez Ruixo JJ; Jiménez Torres NV; Crespo J
Nefrologia; 2004; 24(5):395-409. PubMed ID: 15648900
[No Abstract] [Full Text] [Related]
4. [Cyclosporin in transplantation management--especially after kidney transplantation].
Quellhorst E
Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
[No Abstract] [Full Text] [Related]
5. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
Treĭvish VS; Shoĭkhet IN; Ankova EV
Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
[TBL] [Abstract][Full Text] [Related]
6. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
7. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
8. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Goldfarb DA
J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
[No Abstract] [Full Text] [Related]
9. Is there a rationale to combine cyclosporin and sirolimus?
Kahan BD
Nephrol Dial Transplant; 1996 Jan; 11(1):21-3. PubMed ID: 8649641
[No Abstract] [Full Text] [Related]
10. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
[TBL] [Abstract][Full Text] [Related]
11. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
[No Abstract] [Full Text] [Related]
12. Area under the curve of cyclosporine pharmacokinetics: comparison of the characteristics of the pure drug and metabolites.
Foradori AC; Martínez L; Vacarezza A; Elberg A; Mella G; Loveluck A; Pinto C
Transplant Proc; 1992 Dec; 24(6):2614-5. PubMed ID: 1465884
[No Abstract] [Full Text] [Related]
13. Low-dose OKT3 for cadaveric renal transplantation.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
[No Abstract] [Full Text] [Related]
14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR; Nankivell BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
[No Abstract] [Full Text] [Related]
16. Cyclosporine-related hypercoagulability: fact or fiction?
Edwards CM; Morgan JD; Donnelly PK
Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
[No Abstract] [Full Text] [Related]
17. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
18. Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice.
Campbell SB; Johnson DW
Transplantation; 2003 Jun; 75(11):1917-8. PubMed ID: 12811260
[No Abstract] [Full Text] [Related]
19. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.
Shimazaki J; Den S; Omoto M; Satake Y; Shimmura S; Tsubota K
Am J Ophthalmol; 2011 Jul; 152(1):33-39.e1. PubMed ID: 21570054
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive agents in kidney transplantation].
Nishi S
Nihon Jinzo Gakkai Shi; 2011; 53(1):1-5. PubMed ID: 21370569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
